GelSana Therapeutics
Latest round
- Seed
Last raised
- Nov 2023
Total raised
- $2.5M
Investors
- 1
About GelSana Therapeutics
Founded in 2020 and based in Colorado, US, GelSana Therapeutics, Inc. provides biomaterial products that can be used for the dressing of wounds. As of 2023, the company is headed by its CEO Melissa Krebs, who founded the firm. The company offers gently adhesive hydrogel wound dressing solutions that facilitate wound healing with less inflammation. It protects the wound and softly adheres to the surrounding healthy tissues, lowering the risk of infection and amputation.
Who invested in GelSana Therapeutics
1 investor across 1 round
See all investors in GelSana Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 20, 2023
Amount
$2.5M
Investors
Questions about GelSana Therapeutics
Who invested in GelSana Therapeutics?
GelSana Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GelSana Therapeutics raised?
GelSana Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did GelSana Therapeutics last raise money?
GelSana Therapeutics's most recent round on record is a Seed, in Nov 2023.
What does GelSana Therapeutics do?
Founded in 2020 and based in Colorado, US, GelSana Therapeutics, Inc.
Where is GelSana Therapeutics headquartered?
GelSana Therapeutics is headquartered in Aurora, US.
Which VCs invest in companies like GelSana Therapeutics?
Among active investors with capital left to deploy, S2G Ventures, CAVU Consumer Partners, Gaingels and Alumni Ventures Group back materials companies at GelSana Therapeutics's stage. Their profiles are linked below.
VCs backing materials startups at Seed
Raising like GelSana Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.